Description
"Breaking Alzheimer's: A 15 Year Crusade to Expose the Cause and Deliver the Cure" by Dayan Goodenowe (PhD) examines the biochemical factors behind Alzheimer's disease. The book highlights the role of plasmalogens, essential brain lipids, and their connection to cognitive decline. Goodenowe presents research on how restoring plasmalogen levels may offer a promising approach to prevention and treatment. Exploring these insights can help individuals understand the underlying mechanisms of neurodegeneration and potential strategies for cognitive health.
Author
Dayan Goodenowe
Breaking Alzheimer's: A 15-Year Crusade to Expose the Cause and Deliver the Cure
Support the Author
At this time, the author does not have an official website or active social media channels on platforms like Instagram, Facebook, or Twitter—or they are currently unknown to us. If any updates come to light, we’ll include them here so you can stay connected.
About The Author
Dayan Goodenowe (PhD) is a neuroscientist and founder of Prodrome Sciences, focusing on the biochemical causes of neurological diseases. His book, "Breaking Alzheimer’s: A 15-Year Crusade to Expose the Cause and Deliver the Cure" (2021), highlights the role of low plasmalogen levels in Alzheimer’s. Goodenowe explains his research and explores plasmalogen supplementation as a potential treatment.
Dayan Goodenowe (PhD) is a neuroscientist and founder of Prodrome Sciences, focusing on the biochemical causes of neurological diseases. His book, "Breaking Alzheimer’s: A 15-Year Crusade to Expose the Cause and Deliver the Cure" (2021), highlights the role of low plasmalogen levels in Alzheimer’s. Goodenowe explains his research and explores plasmalogen supplementation as a potential treatment.
Language
English
Topic
Brain Health, Chronic Illnesses, Awakening
ISBN 10|13
XXXXXXXXXX | 979-8521279111
Print Length
242 pages
